EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies

Hirokazu Shoji iD, Narikazu Boku, Jun Adachi iD

Cancer Science · 2026

DOI: 10.1111/cas.70323 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, 2026. Verfasst von Hirokazu Shoji und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Phosphoproteins, Proteomics, Neoplasms, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein phosphorylation is a central post‐translational modification regulating cellular signaling, frequently dysregulated in cancer. Mass spectrometry (MS)‐based phosphoproteomics has emerged as a powerful approach to systematically profile phosphorylation events, thereby revealing aberrant kinase activity and therapeutic vulnerabilities that are not captured by genomic or transcriptomic analyses. Recent advances across the workflow—including optimized sample preparation and phosphopeptide enrichment, isotope‐ or label‐free quantitative strategies, high‐resolution mass spectrometry platforms, specialized algorithms for site identification and quantification, and integrative informatics analyses—have enabled the detection of tens of thousands of phosphorylation sites even from small clinical specimens. These developments have facilitated the characterization of signaling pathways across diverse cancer types, leading to the identification of targetable kinases and informing therapeutic strategies. In this review, we highlight studies that employed phosphoproteomic analyses of clinical specimens or patient‐derived cancer cells to delineate signaling characteristics and to propose and validate therapeutic targets. Collectively, MS‐based phosphoproteomics is poised to become a cornerstone of precision oncology. By enabling comprehensive and quantitative mapping of phosphorylation events, this technology allows mechanistic dissection of cancer signaling pathways and uncovers therapeutic vulnerabilities that may be exploited with targeted agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhosphoproteinsProteomicsNeoplasmsProtein Kinase InhibitorsHumansPhosphorylationMass SpectrometryDrug DiscoveryAntineoplastic AgentsSignal TransductionXenograft Model Antitumor AssaysAnimalsMolecular Targeted TherapyProtein Processing, Post-TranslationalGene Expression Regulation, NeoplasticPrecision Medicine

Stichwörter der Autor:innen

cancer signalingkinasesmass spectrometryphosphoproteomicstherapeutic targets

Substanzen

PhosphoproteinsAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Medical Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health, and Nutrition, Osaka, Japan.
  • Laboratory of Proteomics and Drug Discovery, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.

ORCID-Profile: Hirokazu Shoji, Jun Adachi

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Shoji, H., Boku, N., & Adachi, J. (2026). Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies. Cancer Science. https://doi.org/10.1111/cas.70323

Vancouver

Shoji H, Boku N, Adachi J. Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies. Cancer Science. 2026. doi:10.1111/cas.70323

BibTeX
@article{Shoji2026,
  author = {Shoji, Hirokazu and Boku, Narikazu and Adachi, Jun},
  title = {Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70323}
}
Kostenlos starten →